IASO206 injection

BIOLOGICAL2 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Autoimmune Hemolytic AnemiaRelapsed/RefractoryRelapsed/Refractory Multiple Myeloma (RRMM)

Early Phase 1

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

Not yet recruitingNCT07322159

Institute of Hematology & Blood Diseases Hospital, ChinaRelapsed/Refractory Multiple Myeloma (RRMM)

Start: 2026-01-15End: 2028-10-15Target: 12Updated: 2026-01-07

Phase 1

IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Not yet recruitingNCT07585071

Institute of Hematology & Blood Diseases Hospital, ChinaAutoimmune Hemolytic Anemia, Relapsed/Refractory

Start: 2026-06-15End: 2028-12-31Target: 18Updated: 2026-05-13